Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("VAN DEN ANKER, John")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 64

  • Page / 3
Export

Selection :

  • and

PSYCHOPHARMACOLOGYROBB, Adelaide S; VAN DEN ANKER, John N.Developmental disabilities research reviews. 2010, Vol 16, Num 3, issn 1940-5510, 53 p.Serial Issue

Pain relief in neonates: when to use intravenous paracetamolVAN DEN ANKER, John N; TIBBOEL, Dick.Archives of disease in childhood. 2011, Vol 96, Num 6, pp 573-574, issn 0003-9888, 2 p.Article

How to Optimize the Evaluation and Use of Antibiotics in NeonatesJACQZ-AIGRAIN, Evelyne; KAGUELIDOU, Florentia; VAN DEN ANKER, John N et al.The Pediatric clinics of North America. 2012, Vol 59, Num 5, issn 0031-3955, x-xi, 11117-1128 [12 p.]Article

Pharmacologic Management of the Opioid Neonatal Abstinence SyndromeKRAFT, Walter K; VAN DEN ANKER, John N.The Pediatric clinics of North America. 2012, Vol 59, Num 5, issn 0031-3955, xi, 1147-1165 [19 p.]Article

Neonatal and Pediatric Clinical PharmacologyVAN DEN ANKER, John N; COPPES, Max J; KOREN, Gideon et al.The Pediatric clinics of North America. 2012, Vol 59, Num 5, issn 0031-3955, 244 p.Serial Issue

Vancomycin: Pharmacokinetics and administration regimens in neonatesDE HOOG, Matthijs; MOUTON, Johan W; VAN DEN ANKER, John N et al.Clinical pharmacokinetics. 2004, Vol 43, Num 7, pp 417-440, issn 0312-5963, 24 p.Article

A review of pharmaceutical labeling for overdose treatment and toxicity dataMAZER-AMIRSHAHI, Maryann; SOKOL, Gerald; VAN DEN ANKER, John et al.Pharmacoepidemiology and drug safety. 2013, Vol 22, Num 3, pp 319-323, issn 1053-8569, 5 p.Article

Pharmacological research in pediatrics : From neonates to adolescentsRAKHMANINA, Natella Y; VAN DEN ANKER, John N.Advanced drug delivery reviews. 2006, Vol 58, Num 1, pp 4-14, issn 0169-409X, 11 p.Article

New Ways to Detect Adverse Drug Reactions in PediatricsRIEDER, Michael.The Pediatric clinics of North America. 2012, Vol 59, Num 5, issn 0031-3955, x, 1071-1092 [20 p.]Article

DEVELOPMENTAL PHARMACOLOGYVAN DEN ANKER, Johannes N.Developmental disabilities research reviews. 2010, Vol 16, Num 3, pp 233-238, issn 1940-5510, 6 p.Article

Pharmacogenetics of morphine : Potential implications in sickle cell diseaseDARBARI, Deepika S; MINNITI, Caterina P; RANA, Sohail et al.American journal of hematology. 2008, Vol 83, Num 3, pp 233-236, issn 0361-8609, 4 p.Article

MANAGING IRRITABILITY AND AGGRESSION IN AUTISM SPECTRUM DISORDERS IN CHILDREN AND ADOLESCENTSROBB, Adelaide S.Developmental disabilities research reviews. 2010, Vol 16, Num 3, pp 258-264, issn 1940-5510, 7 p.Article

REVIEW OF PHARMACOTHERAPY OPTIONS FOR THE TREATMENT OF ATTENTION-DEFICIT/ HYPERACTIVITY DISORDER (ADHD) AND ADHD-LIKE SYMPTOMS IN CHILDREN AND ADOLESCENTS WITH DEVELOPMENTAL DISORDERSROWLES, Brieana M; FINDLING, Robert L.Developmental disabilities research reviews. 2010, Vol 16, Num 3, pp 273-282, issn 1940-5510, 10 p.Article

In Vivo Glucuronidation Activity of Drugs in Neonates: Extensive Interindividual Variability Despite Their Young AgeALLEGAERT, Karel; VANHAESEBROUCK, Sophie; VERBESSELT, Rene et al.Therapeutic drug monitoring. 2009, Vol 31, Num 4, pp 411-415, issn 0163-4356, 5 p.Article

13C-erythromycin breath test as a noninvasive measure of CYP3A activity in newborn infants : A pilot studyDE WILDT, Saskia N; BERNS, Michiel J. P; VAN DEN ANKER, John N et al.Therapeutic drug monitoring. 2007, Vol 29, Num 2, pp 225-230, issn 0163-4356, 6 p.Article

Information technology cannot guarantee patient safetyDE WILDT, Saskia N; VERZIJDEN, Ron; VAN DEN ANKER, John N et al.BMJ. British medical journal (International ed.). 2007, Vol 334, Num 7598, pp 851-852, issn 0959-8146, 2 p.Article

NONMEM and NPEM2 population modeling: A comparison using tobramycin data in neonatesDE HOOG, Matthijs; SCHOEMAKER, Rik C; VAN DEN ANKER, John N et al.Therapeutic drug monitoring. 2002, Vol 24, Num 3, pp 359-365, issn 0163-4356Article

Improving Drug Formulations for Neonates: Making a Big Difference in Our Smallest PatientsNOEL, Gary J; VAN DEN ANKER, John N; LOMBARDI, Donald et al.The Journal of pediatrics. 2012, Vol 161, Num 5, pp 947-949, issn 0022-3476, 3 p.Article

Pharmacotherapy for Pulmonary HypertensionSTEINHORN, Robin H.The Pediatric clinics of North America. 2012, Vol 59, Num 5, issn 0031-3955, xi, 1129-1146 [16 p.]Article

Emerging Biomarkers of Intrauterine Neonatal and Pediatric Exposures to XenobioticsDELANO, Kaitlyn; KOREN, Gideon.The Pediatric clinics of North America. 2012, Vol 59, Num 5, issn 0031-3955, x, 1059-1070 [11 p.]Article

PHARMACOTHERAPY OF DISRUPTIVE BEHAVIOR IN MENTALLY RETARDED SUBJECTS: A REVIEW OF THE CURRENT LITERATUREHÄSSLER, Frank; REIS, Olaf.Developmental disabilities research reviews. 2010, Vol 16, Num 3, pp 265-272, issn 1940-5510, 8 p.Article

Renal drug clearance in preterm neonates: Relation to prenatal growthALLEGAERT, Karel; ANDERSON, Brian J; VAN DEN ANKER, John N et al.Therapeutic drug monitoring. 2007, Vol 29, Num 3, pp 284-291, issn 0163-4356, 8 p.Article

The Impact of Extracorporeal Life Support and Hypothermia on Drug Disposition in Critically III Infants and ChildrenWILDSCHUT, Enno D; VAN SAET, Annewil; POKORNA, Pavla et al.The Pediatric clinics of North America. 2012, Vol 59, Num 5, issn 0031-3955, xi-xii, 1183-1204 [21 p.]Article

Update on Pain Assessment in Sick Neonates and InfantsVAN DIJK, Monique; TIBBOEL, Dick.The Pediatric clinics of North America. 2012, Vol 59, Num 5, issn 0031-3955, xi, 1167-1181 [14 p.]Article

Extended-interval dosing of tobramycin in neonates: Implications for therapeutic drug monitoringDE HOOG, Matthijs; MOUTON, Johan W; SCHOEMAKER, Rik C et al.Clinical pharmacology and therapeutics. 2002, Vol 71, Num 5, pp 349-358, issn 0009-9236Article

  • Page / 3